- The Food and Drug Administration (FDA) has approved a novel first-in-class drug to treat type 2 diabetes. The drug is called tirzepatide.
- A person has it as a once-weekly injection under the skin.
- It has a dual effect, lowering blood sugar and supporting weight loss better than currently available drugs for this condition.
- The most common side effects are nausea, diarrhea, and vomiting, which appear to lessen with time. There were also a few reports of severe low blood sugar in clinical trials.
